Bal Pharma consolidated net profit rises 225.00% in the June 2024 quarter

Net profit of Bal Pharma rose 225.00% to Rs 0.26 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 5.64% to Rs 74.36 crore in the quarter ended June 2024 as against Rs 70.39 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	74.36	70.39	6
OPM %	8.69	9.15	-
PBDT	3.05	2.96	3
PBT	0.62	0.43	44
NP	0.26	0.08	225